Cardiovascular Risk Assessment and Management in Developing Countries by Mendis, Shanthi
Vascular Health and Risk Management 2005:1(1) 15–18
© 2005 Dove Medical Press Limited. All rights reserved
15
COMMENTARY
Abstract: Causes of the burgeoning cardiovascular epidemic in developing countries (DC)
are known. Whilst there are many prevention strategies and policies demonstrated to be effective
in reducing the trends of cardiovascular disease in developed countries, applying them in DCs
is challenging and complex. To utilize resources efficiently, two key decisions have to be
made by policy makers in all DCs. The first is to decide on the appropriate mix of population
and high-risk interventions. The second is to determine the threshold for implementing high-
risk interventions. In making such decisions, due consideration needs to be given to scientific
evidence, affordability, sustainability, opportunity costs, and social and political realities. High-
risk approaches can be made cost-effective if individuals that are most likely to benefit from
treatment can be identified through risk stratification systems. Although several such risk
prediction systems are available, they have limited applicability to non-Western populations.
Further, health systems in DCs do not have basic infrastructure facilities to support resource
intensive risk prediction tools, particularly in primary healthcare. The World Health
Organization has developed a flexible cardiovascular disease risk management package that
is implemented in a range of less resourced settings. A risk prediction tool that enables more
accurate prediction of cardiovascular risk in DCs is in development.
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Cardiovascular disease (CVD) is a major cause of mortality and morbidity worldwide.
Currently, 80% of deaths and 87% of disability due to CVD occur in developing
countries (WHO 2002a, 2003a). CVD is already placing a heavy burden on the health
services of developing countries, which are barely coping with communicable
diseases. Effective strategies for the prevention and control of CVD are imperative.
Causes of CVD are known
Tobacco use, physical inactivity, and unhealthy diet and their intermediate
manifestations – hypertension, hyperlipidemia, and hyperglycemia – explain at least
75% of the CVD burden (Magnus and Beaglehole 2001; Emberson et al 2004; Yusuf
et al 2004). Other established risk factors for CVD include age, gender, obesity,
personal history of CVD, family history of CVD, and socioeconomic position. These
risk factors often cluster together (Ebrahim 2004). At any given time, about 5%–10%
of the population are at very high risk of developing cardiovascular events (Figure 1).
A much larger segment of the population is at moderate risk. If no preventive action
is taken, individuals at the tail end of the distribution will develop fatal and nonfatal
cardiovascular events. Many more events will occur in the segment of the population
with modest elevation of risk, as the number of individuals in this segment is larger.
As such, it is essential that population-based strategies are used to shift the risk
distribution of the whole population to the left, and that high-risk strategies are used
to deal with those at very high risk and for whom drug treatment may be indicated
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(WHO 2001, 2003b). These preventive strategies are
complimentary and synergistic, and dovetail into each other
in terms of targeting risk groups. The World Health Report
(2002) examined the cost-effectiveness of several
population-wide strategies to reduce cardiovascular risk
(WHO 2002a). The combination of population-based
cholesterol reduction strategies with interventions to reduce
salt intake at the population level was found to be very cost-
effective in all settings. The most attractive population-wide
strategies were salt reduction at a population level through
legislation and voluntary agreements, health education
through mass media focusing on blood pressure cholesterol
and body mass, and promoting fruit and vegetable intake
through national education campaigns (WHO 2002a).
Difficulties in implementing what
is known
For effective prevention and control of CVD there are two
major policy questions that need to be addressed upfront.
The first question is how to strike an appropriate balance
between population-based and high-risk approaches. The
second is where to place the threshold for implementing
high-risk strategies. There are no blueprints for the process,
and the answers will depend on the economic, political, and
social realities of each country. For example, very low-
income countries may have to decide to place the threshold
for implementing high-risk strategies at a 10-year risk of
CVD at 30%. Other countries with additional resources may
lower it to 20%. As the threshold is lowered, health benefits
increase and costs escalate. Making these decisions is so
challenging that decision makers often avoid addressing the
above questions through an explicit and transparent process.
Given the limited healthcare resources, high-risk
approaches also need to be prioritized. They need to first
target the following segments of the population who are in
greatest need and are most likely to benefit. This includes
people with:
• established coronary heart disease, cerebrovascular
disease, peripheral vascular disease, and other types of
heart disease;
• diabetes and nephropathy;
• genetic lipid disorders such as familial hyper-
cholesterolemia;
• no apparent CVD but at high risk of developing
atherosclerotic disease because of markedly elevated
single risk factors (eg, total cholesterol ≥ 8 mmol/L or
blood pressure ≥ 180/110 mmHg);
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• no apparent CVD but at high risk of developing
atherosclerotic vascular disease due to a combination of
cardiovascular risk factors;
• metabolic syndrome.
At present in most developing countries there are no
organized schemes for detecting the above categories of
individuals. Primary care has an important role to play in
the effective delivery of high-risk strategies as the majority
of the population has contact with primary care for their
health needs. However, currently, human resource and
infrastructure capacity at primary care level in most
developing countries is grossly inadequate to serve this
function (Mendis et al 2004). With current levels of
healthcare expenditure, most developing countries are also
in no position to upgrade primary healthcare facilities to
take on these tasks of screening, diagnosis, and effective
intervention for chronic conditions that need lifelong care.
Further, if due to resource constraints such services do not
cover the entire population, it may result in widening of
inequities in the distribution of resources for health.
Recommended approach to
cardiovascular risk assessment
As alluded to above, risk factors often cluster together and
the majority of cardiovascular events occur in individuals
with modest elevations of several risk factors than in
individuals with marked elevation of a single risk factor.
Therefore, focusing on cholesterol or blood pressure levels
separately to identify high-risk individuals is not cost-
effective. A more cost-effective approach is to base treatment
decisions on each individual’s risk of a cardiovascular event
in the foreseeable future (WHO 2003a). This approach
enables the selection of those that are most likely to benefit
from treatment through risk stratification and improves
health outcomes. It is of particular importance to settings
with scarce resources.
To date, several risk prediction equations have been
developed to measure an individual’s absolute risk of a
cardiovascular event over a specified time period. These
equations have largely been derived from highly selected
populations. The Framingham coronary heart disease risk
function is the most widely used method for assessment of
cardiovascular risk. It is derived by observing the cumulative
number of cardiovascular events in the original Framingham
cohort and subjects of the Framingham offspring study who
were followed for 4–12 years (Anderson et al 1990). The
Framingham analysis forms the basis of some commonly
used guidelines and risk tables such as the Sheffield and
New Zealand tables. Although Framingham risk equations
give an acceptable prediction of risk in North American
populations, they have been shown to substantially
overestimate the risk for other populations (Brindle et al
2003). The European SCORE project has developed risk
assessment charts using pooled data from 12 European
cohorts, and these are applicable only to European
populations (Conroy et al 2003).
Applying risk prediction systems in
developing countries
There are complex challenges in applying cardiovascular
risk prediction systems in developing countries. Health
systems in low-income countries do not have basic
infrastructure facilities to support resource intensive risk
prediction tools, particularly in primary healthcare. WHO
has developed a flexible CVD risk management package
that can be implemented with the infrastructure available in
a range of less resourced settings (WHO 2002c, 2002d).
This package enables cardiovascular risk to be stratified into
low, medium, and high-risk categories based on history,
blood pressure measurement, and urine analysis.
A risk prediction tool that enables more accurate
prediction of cardiovascular risk in non-Western populations
is been developed. It uses gender, blood pressure, smoking
status, diabetes, and total cholesterol to quantify the 10-
year cardiovascular risk. In settings where total cholesterol
assay is not routinely available average values derived from
national surveys could be used as default concentrations.
Serum lipid assays could then be done only in those with an
initial coronary risk above a predetermined cutoff level (eg,
30% or more risk of CVD in 10 years). This would help to
further select those who would benefit most from treatment,
and guide the intensity and nature of drug treatment.
Developing a simple and accurate risk prediction tool that
is sufficiently flexible to be used in a variety of resource
settings is a challenge. Due consideration also needs to be
given to opportunity costs and service consequences that
may entail the application of such a tool.
CVD is already a leading cause of death and disability
in most developing countries except those in sub-Saharan
Africa. Tobacco smoking, physical inactivity, unhealthy diet,
and accompanying obesity are responsible for at least 75%
of CVD, mainly through their effects on blood pressure,
blood sugar, and blood lipids. These conventional
cardiovascular risk factors are becoming more prevalent inVascular Health and Risk Management 2005:1(1) 18
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all populations of the developing world. Strategies targeting
the primary and secondary prevention of high-risk
individuals are urgently required to contain the epidemic.
Such strategies are necessary to exert an immediate
measurable impact on the current cardiovascular morbidity
and mortality rates. However, investment in population-
based strategies, which have the potential to prevent the
epidemic in the long-term, is essential and is affordable even
to low income countries. Developing and implementing
balanced public health policies that address the
cardiovascular risk at individual and population-wide level
are urgently required to curb the burgeoning cardiovascular
epidemic in developing countries.
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